Mirror, mirror on the wall, which is the best cell of them all? If you are considering incorporating Organ-on-a-chip (OOC) technology into your
CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for microphysiological systems
Partnership to provide customers with direct access to portfolio of highly characterized hepatic cells to recreate advanced Liver-on-a-Chip
CN Bio appoints Dr. Tomasz Kostrzewski as Chief Scientific Officer
Cambridge, UK, 30th August 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ
CN Bio appoints Dr. Samantha Macro as Chief Financial Officer
Cambridge, UK, 06 June 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological
Immune-mediated DILI – Predicting the unpredictable!
Different types of Drug-induced Liver Injury (DILI) Drug-induced liver injury (DILI) is a longstanding and significant problem for clinicians,
CN Bio appoints Deepak Singh as Vice President of Sales and Marketing
Cambridge, UK, 14 March 2023: CN Bio, a leading Organ-on-a-chip (OOC) company that designs and manufactures single-and multi-organ microphysiological
CN Bio extends microphysiological system portfolio with PhysioMimix Single-Organ Higher Throughput System
Cambridge, UK, CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS),
The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system
Cambridge, UK, 17th January 2023: CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ
The U.S. FDA Modernization Act 2.0. Now the animal testing mandate is removed, learn what can be embraced in its place.
What is the FDA Modernization Act 2.0, and what does it mean? The U.S. Food and Drug Administration (FDA) are the federal agency tasked with